Braemar Hotels & Resorts Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Braemar Hotels & Resorts Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $121.70M | Mar 13, 2020 |
| FY2019 | Sep 30, 2019 | $118.88M | Mar 13, 2020 |
| FY2019 | Jun 30, 2019 | $118.52M | Mar 13, 2020 |
| FY2019 | Mar 31, 2019 | $128.51M | Mar 13, 2020 |
| FY2019 | Dec 31, 2018 | $98.95M | Mar 13, 2020 |
| FY2019 | Sep 30, 2018 | $108.85M | Mar 13, 2020 |
| FY2019 | Jun 30, 2018 | $121.12M | Mar 13, 2020 |
| FY2019 | Mar 31, 2018 | $102.49M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $92.56M | Mar 8, 2019 |
| FY2018 | Sep 30, 2017 | $108.12M | Mar 8, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $704.02M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $728.40M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $739.34M | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $669.59M | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | $427.54M | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | $226.97M | Mar 10, 2023 |
| FY2021 | Dec 31, 2019 | $487.61M | Mar 10, 2022 |
| FY2020 | Dec 31, 2018 | $431.40M | Mar 5, 2021 |
| FY2018 | Dec 31, 2017 | $414.06M | Mar 8, 2019 |
| FY2018 | Dec 31, 2016 | $405.86M | Mar 8, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($22.32M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($1.69M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | ($27.02M) | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $17.76M | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | ($26.66M) | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | ($105.26M) | Mar 10, 2023 |
| FY2019 | Dec 31, 2019 | $15.25M | Mar 13, 2020 |
| FY2019 | Sep 30, 2019 | ($9.39M) | Mar 13, 2020 |
| FY2019 | Jun 30, 2019 | ($4.51M) | Mar 13, 2020 |
| FY2019 | Mar 31, 2019 | ($981.0K) | Mar 13, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $72.36M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $128.75M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $61.67M | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $68.39M | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | $1.45M | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | ($79.85M) | Mar 10, 2023 |
| FY2019 | Dec 31, 2019 | $30.29M | Mar 13, 2020 |
| FY2019 | Sep 30, 2019 | $7.32M | Mar 13, 2020 |
| FY2019 | Jun 30, 2019 | $12.72M | Mar 13, 2020 |
| FY2019 | Mar 31, 2019 | $14.08M | Mar 13, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $40.78M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $66.82M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $84.71M | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $109.48M | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | $63.95M | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | ($50.29M) | Mar 10, 2023 |
| FY2021 | Dec 31, 2019 | $66.26M | Mar 10, 2022 |
| FY2020 | Dec 31, 2018 | $70.73M | Mar 5, 2021 |
| FY2019 | Dec 31, 2017 | $70.61M | Mar 13, 2020 |
| FY2018 | Dec 31, 2016 | $58.61M | Mar 8, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.86B | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $2.14B | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $2.23B | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $2.40B | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $1.88B | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $1.67B | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | $1.76B | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $1.64B | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $1.42B | Mar 8, 2019 |
| FY2017 | Dec 31, 2016 | $1.26B | Mar 14, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.34B | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.41B | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $1.41B | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $1.57B | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $1.36B | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $1.28B | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | $1.25B | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $1.09B | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $894.52M | Mar 8, 2019 |
| FY2017 | Dec 31, 2016 | $828.06M | Mar 14, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $138.68M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $240.73M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $306.98M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $410.11M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $398.85M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $276.26M | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | $369.27M | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $397.48M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $381.31M | Mar 8, 2019 |
| FY2017 | Dec 31, 2016 | $308.80M | Mar 14, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($568.50M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($477.80M) | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | ($412.20M) | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | ($324.74M) | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | ($309.24M) | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | ($266.01M) | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | ($150.63M) | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | ($115.41M) | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | ($88.81M) | Mar 8, 2019 |
| FY2017 | Dec 31, 2016 | ($93.25M) | Mar 14, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $124.35M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $135.47M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $85.60M | Mar 12, 2026 |
| FY2025 | Dec 31, 2022 | $261.54M | Mar 12, 2026 |
| FY2024 | Dec 31, 2021 | $216.00M | Mar 12, 2025 |
| FY2023 | Dec 31, 2020 | $78.61M | Mar 14, 2024 |
| FY2022 | Dec 31, 2019 | $72.00M | Mar 10, 2023 |
| FY2021 | Dec 31, 2018 | $182.58M | Mar 10, 2022 |
| FY2020 | Dec 31, 2017 | $137.52M | Mar 5, 2021 |
| FY2019 | Dec 31, 2016 | $126.79M | Mar 13, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.10B | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.21B | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $1.16B | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $1.33B | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $1.17B | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $1.13B | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | $1.06B | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $985.87M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $820.96M | Mar 8, 2019 |
| FY2017 | Dec 31, 2016 | $764.62M | Mar 14, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | (3) | Mar 10, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Mar 10, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Mar 5, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Mar 13, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Mar 8, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | (3) | Mar 10, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 13, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 13, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 13, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 13, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 68.22M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 66.61M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | 66.64M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | 69.92M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | 65.37M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | 38.27M | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | 32.89M | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | 32.51M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | 32.12M | Mar 8, 2019 |
| FY2017 | Dec 31, 2016 | 26.02M | Mar 14, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $47.34M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $51.56M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $52.56M | Mar 12, 2026 |